• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿外泌体 microRNAs 作为 IgA 肾病新型无创生物标志物。

Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy.

机构信息

Clinical Laboratory, The Fifth Hospital of Shanxi Medical University.

Department of Nephrology, The Fifth Hospital of Shanxi Medical University.

出版信息

Tohoku J Exp Med. 2022 Mar;256(3):215-223. doi: 10.1620/tjem.256.215.

DOI:10.1620/tjem.256.215
PMID:35314529
Abstract

Immunoglobulin A nephropathy (IgAN) is the most common type of primary glomerulonephritis. It is very important to find new noninvasive biomarkers for the diagnosis and treatment of IgAN. The purpose of this study was to explore the clinical value of urinary exosomal miRNAs in IgAN. In this study, urinary exosomes were isolated from 29 IgAN patients and 29 healthy controls. The miRNA was analyzed by high-throughput sequencing. The expression of hsa-miR-451a and hsa-let-7d-3p was examined by real-time quantitative polymerase chain reaction (RT-qPCR). The diagnostic value of miRNAs was evaluated using receiver operating characteristic (ROC) curves. Here, hsa-miR-451a and hsa-let-7d-3p were upregulated in IgAN patients compared with healthy controls. We evaluated the diagnostic value of hsa-miR-451a and hsa-let-7d-3p using ROC curves; hsa-miR-451a (AUC = 0.805, p = 0.001), hsa-mir-7d-3p (AUC = 0.76, p = 0.0049), and the combination of hsa-miR-451a and hsa-let-7d-3p (AUC = 0.8125, p = 0.0007). Hsa-miR-451a has correlations with Lee's grades (r = 0.511, p = 0.021), and 24-h urinary protein excretion (UPE; r = 0.557, p = 0.011). Hsa-let-7d-3p showed correlations with Lee's grades (r = 0.6, p = 0.005), UPE (r = 0.518, p = 0.019), serum creatinine (r = 0.564, p = 0.01), and estimated glomerular filtration rate (r = -0.532, p = 0.016). According to the Oxford classification, for hsa-miR-451a, S0 had lower levels than S1 (p = 0.016); for hsa-mir-7d-3p, M0 had lower levels than M1 (p = 0.05). These findings suggest that hsa-miR-451a and hsa-let-7d-3p may serve as noninvasive biomarkers for the evaluation of IgAN.

摘要

免疫球蛋白 A 肾病(IgAN)是最常见的原发性肾小球肾炎。寻找新的非侵入性生物标志物对 IgAN 的诊断和治疗非常重要。本研究旨在探讨尿外泌体 miRNAs 在 IgAN 中的临床价值。在这项研究中,从 29 例 IgAN 患者和 29 例健康对照者中分离尿外泌体。通过高通量测序分析 miRNA。实时定量聚合酶链反应(RT-qPCR)检测 hsa-miR-451a 和 hsa-let-7d-3p 的表达。使用受试者工作特征(ROC)曲线评估 miRNA 的诊断价值。结果显示,与健康对照组相比,IgAN 患者的 hsa-miR-451a 和 hsa-let-7d-3p 表达上调。我们使用 ROC 曲线评估 hsa-miR-451a 和 hsa-let-7d-3p 的诊断价值;hsa-miR-451a(AUC=0.805,p=0.001),hsa-mir-7d-3p(AUC=0.76,p=0.0049),hsa-miR-451a 和 hsa-let-7d-3p 的组合(AUC=0.8125,p=0.0007)。hsa-miR-451a 与 Lee 分级(r=0.511,p=0.021)和 24 小时尿蛋白排泄量(UPE;r=0.557,p=0.011)相关。hsa-let-7d-3p 与 Lee 分级(r=0.6,p=0.005)、UPE(r=0.518,p=0.019)、血清肌酐(r=0.564,p=0.01)和估计肾小球滤过率(r=-0.532,p=0.016)相关。根据牛津分类,对于 hsa-miR-451a,S0 水平低于 S1(p=0.016);对于 hsa-mir-7d-3p,M0 水平低于 M1(p=0.05)。这些发现表明 hsa-miR-451a 和 hsa-let-7d-3p 可能作为评估 IgAN 的非侵入性生物标志物。

相似文献

1
Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy.尿外泌体 microRNAs 作为 IgA 肾病新型无创生物标志物。
Tohoku J Exp Med. 2022 Mar;256(3):215-223. doi: 10.1620/tjem.256.215.
2
Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy.IgA肾病中尿微小RNA作为生物标志物的分析及初步验证
PeerJ. 2015 Jun 2;3:e990. doi: 10.7717/peerj.990. eCollection 2015.
3
Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy.尿外泌体 miRNA-451a 可用作潜在的无创生物标志物,用于 IgA 肾病的诊断,反映肾小管间质损伤和治疗反应。
Ren Fail. 2024 Dec;46(1):2319326. doi: 10.1080/0886022X.2024.2319326. Epub 2024 Feb 20.
4
Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.从血清外泌体 microRNAs 中鉴定慢性萎缩性胃炎的非侵入性生物标志物。
BMC Cancer. 2019 Feb 8;19(1):129. doi: 10.1186/s12885-019-5328-7.
5
Differential expression of urinary exosomal microRNAs in IgA nephropathy.IgA肾病中尿外泌体微小RNA的差异表达
J Clin Lab Anal. 2018 Feb;32(2). doi: 10.1002/jcla.22226. Epub 2017 Apr 6.
6
Evidence for the circulating microRNA hsa-let-7d-3p as a potential new biomarker for sepsis in human subjects.循环 microRNA hsa-let-7d-3p 作为人类脓毒症潜在新生物标志物的证据。
Eur J Med Res. 2022 Jul 30;27(1):137. doi: 10.1186/s40001-022-00763-3.
7
Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.IgA 肾病患者尿液外泌体 microRNAs 的临床意义。
Sci Rep. 2023 Oct 11;13(1):17201. doi: 10.1038/s41598-023-44460-5.
8
Plasma microRNA signature of patients with IgA nephropathy.IgA肾病患者的血浆微小RNA特征
Gene. 2018 Apr 5;649:80-86. doi: 10.1016/j.gene.2018.01.050. Epub 2018 Feb 6.
9
Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.选择尿沉渣微小RNA作为IgA肾病的特异性生物标志物。
Sci Rep. 2016 Mar 22;6:23498. doi: 10.1038/srep23498.
10
Urinary exosomal miRNA signature of IgA nephropathy: a case-control study.IgA 肾病尿外泌体 miRNA 特征:一项病例对照研究。
Sci Rep. 2023 Dec 4;13(1):21400. doi: 10.1038/s41598-023-47751-z.

引用本文的文献

1
Urinary microvesicles: a window into the kidney.尿微泡:了解肾脏的一扇窗口。
Clin Kidney J. 2025 Jun 17;18(7):sfaf189. doi: 10.1093/ckj/sfaf189. eCollection 2025 Jul.
2
Exosomes applications in kidney diseases.外泌体在肾脏疾病中的应用。
Mol Biol Rep. 2025 Jun 21;52(1):622. doi: 10.1007/s11033-025-10727-5.
3
Emerging roles of exosomes in the diagnosis and treatment of kidney diseases.外泌体在肾脏疾病诊断和治疗中的新作用。
Front Pharmacol. 2025 Apr 16;16:1525314. doi: 10.3389/fphar.2025.1525314. eCollection 2025.
4
Small extracellular vesicles: the origins, current status, future prospects, and applications.小细胞外囊泡:起源、现状、未来前景及应用
Stem Cell Res Ther. 2025 Apr 17;16(1):184. doi: 10.1186/s13287-025-04330-5.
5
Urinary exosomes as promising biomarkers for early kidney disease detection.尿外泌体作为早期肾病检测的有前景的生物标志物。
Am J Clin Exp Urol. 2025 Feb 15;13(1):1-19. doi: 10.62347/DAKE5842. eCollection 2025.
6
Non-invasive assessment of IgA nephropathy severity with [F]AlF-NOTA-FAPI-04 PET/CT imaging.使用[F]AlF-NOTA-FAPI-04 PET/CT成像对IgA肾病严重程度进行无创评估。
Clin Kidney J. 2024 Nov 11;17(12):sfae340. doi: 10.1093/ckj/sfae340. eCollection 2024 Dec.
7
Panel miRNAs are potential diagnostic markers for chronic kidney diseases: a systematic review and meta-analysis.面板 miRNA 是慢性肾脏病的潜在诊断标志物:系统评价和荟萃分析。
BMC Nephrol. 2024 Aug 13;25(1):261. doi: 10.1186/s12882-024-03702-y.
8
Blood and urine biomarkers of disease progression in IgA nephropathy.IgA肾病疾病进展的血液和尿液生物标志物
Biomark Res. 2024 Jul 29;12(1):72. doi: 10.1186/s40364-024-00619-4.
9
Podocyte-specific proteins in urinary extracellular vesicles of patients with IgA nephropathy: Vasorin and ceruloplasmin.IgA肾病患者尿细胞外囊泡中的足细胞特异性蛋白:血管紧张素原和铜蓝蛋白。
Bioimpacts. 2024;14(3):29981. doi: 10.34172/bi.2023.29981. Epub 2023 Oct 31.
10
Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy.尿外泌体 miRNA-451a 可用作潜在的无创生物标志物,用于 IgA 肾病的诊断,反映肾小管间质损伤和治疗反应。
Ren Fail. 2024 Dec;46(1):2319326. doi: 10.1080/0886022X.2024.2319326. Epub 2024 Feb 20.